title: Adherence to hepatitis B immunoglobulin (HBIG) after liver transplantation.
authors.affiliation: 1 Division of Gastroenterology Hepatology and Endoscopy Brigham and Women's Hospital Boston, MA 2 Center for Liver Disease and Transplantation New York Presbyterian Hospital-Columbia University New York, NY 3 Division of Gastroenterology and Hepatology University of California-San Francisco San Francisco, CA.
authors.forename: Matthew S
authors.initials: MS
authors.lastname: Chang
authors.forename: Jessica B
authors.initials: JB
authors.lastname: Stiles
authors.forename: Thresiamma S
authors.initials: TS
authors.lastname: Lukose
authors.forename: Anastasia
authors.initials: A
authors.lastname: Balducci
authors.forename: William D
authors.initials: WD
authors.lastname: Brubaker
authors.forename: Blaire E
authors.initials: BE
authors.lastname: Burman
authors.forename: Jean C
authors.initials: JC
authors.lastname: Emond
authors.forename: Robert S
authors.initials: RS
authors.lastname: Brown
mesh_terms: D015415:Biomarkers / Q000097:blood; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D005260:Female; D006509:Hepatitis B / Q000097:blood / Q000175:diagnosis / Q000517:prevention & control*; D006510:Hepatitis B Antibodies / Q000097:blood; D018718:Home Infusion Therapy; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage*; D007262:Infusions, Intravenous; D016031:Liver Transplantation / Q000009:adverse effects / Q000401:mortality; D008297:Male; D055118:Medication Adherence; D008875:Middle Aged; D012189:Retrospective Studies; D055502:Secondary Prevention; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D006510:Hepatitis B Antibodies; D007136:Immunoglobulins; C045213:hepatitis B hyperimmune globulin